Categories
Archives
Receive Email Updates
-
-
-
Certified Licensing Professionals, Inc., 2021 
Disclaimer
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
-
- About Me
Warren D. Woessner
Pages
Archives
Tag Archives: Chakrabarty
USPTO s.101 Guidelines – How to “Eviscerate Patent Law”
On March 19th, the USPTO released 93 slides as training materials to help Examiners navigate the lengthy ”Guidelines for Subject Matter Eligibility Analysis of Claims Reciting or Involving Laws of Nature,” et al. (A copy of the slides is available … Continue reading →
AMP Petitions for Cert. and A Look Back
The Association for Molecular Pathology (AMP) has petitioned the Supreme Court to review the Fed. Cir.’s opinion of July 29th, that isolated BRCA DNA sequences are patentable subject matter. Its brief (a copy available at the end of this post) … Continue reading →
Posted in Patent Eligible Subject Matter
|
Tagged ACLU, AMP, Association of Molecular Pathology, biotechnology, biotechnology law, biotechnology news, BRCA DNA, Chakrabarty, diagnostic methods, Federal Circuit, Myriad, Myriad lawsuit, patent attorney, Patent Law, patents, SLW, Supreme Court, Warren Woessner
|
1 Comment
Wegner Paper Probes Myriad Decisions Flaws
Prof. Hal Wegner goes for the jugular with his analysis of some of the flaws in the legal reasoning behind the holding in the recent AMC v. Myriad decision. [See my post of July 31st 2011 on the decision]. (Prof. … Continue reading →
IN SEARCH OF CHAKRABARTY, “NATURAL PHENOMENA” AND WHERE BILSKI WENT BAD, WITH A GLANCE BACK AT ARIAD.
I was finishing up my recent comment on the reexamination proceedings involving the Baltimore et al. patent, when a fragment of one of the Office Actions caught my eye and stuck in my mind. The Examiner is trying to explain … Continue reading →
Posted in Patent Eligible Subject Matter
|
Tagged Ariad, Bilski, Chakrabarty, Federal Circuit, intellectual property, ip, USPTO, Warren Woessner
|
Leave a comment